Kendall from Wall Street Journal writes about a big win for investors against Pfizer, Inc for fraud. Big News!
High Court Rejects Pfizer Appeal in Investor Suit
BY BRENT KENDALL
WASHINGTON—The U.S. Supreme Court on Monday rejected an appeal by Pfizer Inc. that sought to thwart a securities lawsuit alleging the drugmaker misrepresented the safety profile of the blockbuster pain drug Celebrex.
The plaintiffs alleged that Pfizer's Pharmacia unit deliberately withheld the full results of a medical study that showed no safety advantage to using Celebrex over less expensive anti-inflammatory drugs.
Pfizer argued that investors missed a two-year statute of limitations to bring the lawsuit. The investors said there was no evidence of a possible fraud until the Washington Post published ...
for more go to WSJ link: http://online.wsj.com/article/SB10001424052748704342604575222070480923454.html?reflink=barrons_redirect